Rahul S. Desikan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rahul S. Desikan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Bruce Fischl
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
2 shared publications- Christopher P. Hess
Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143
2 shared publications David H. Salat
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America
2 shared publications- Howard Cabral
Department of Biostatistics, School of Public Health, Boston University Chobanian & Avedisian School of Medicine, Boston, MA
2 shared publications - Mert Rory Sabuncu
Cornell University
2 shared publications Michael W. Weiner
Department of Radiology, University of California San Francisco, San Francisco, California, United States of America
2 shared publications
Latest Publications
- Open Access
- 23 September 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9) , e12853
Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
Alzheimer's disease (AD) and its transitional state mild cognitive impairment (MCI) are characterized by amyloid plaque and tau neurofibrillary tangle (NFT) deposition within the cerebral neocortex and neuronal loss within the hippocampal formation. However, the precise relationship between pathologic changes in neocortical regions and hippocampal atrophy is largely unknown. In this study, combining structural MRI scans and automated image analysis tools with reduced cerebrospinal fluid (CSF) Aß levels, a surrogate for intra-cranial amyloid plaques and elevated CSF phosphorylated tau (p-tau) levels, a surrogate for neocortical NFTs, we examined the relationship between the presence of Alzheimer's pathology, gray matter thickness of select neocortical regions, and hippocampal volume in cognitively normal older participants and individuals with MCI and AD (n = 724). Amongst all 3 groups, only select heteromodal cortical regions significantly correlated with hippocampal volume. Amongst MCI and AD individuals, gray matter thickness of the entorhinal cortex and inferior temporal gyrus significantly predicted longitudinal hippocampal volume loss in both amyloid positive and p-tau positive individuals. Amongst cognitively normal older adults, thinning only within the medial portion of the orbital frontal cortex significantly differentiated amyloid positive from amyloid negative individuals whereas thinning only within the entorhinal cortex significantly discriminated p-tau positive from p-tau negative individuals. Cortical Aβ and tau pathology affects gray matter thinning within select neocortical regions and potentially contributes to downstream hippocampal degeneration. Neocortical Alzheimer's pathology is evident even amongst older asymptomatic individuals suggesting the existence of a preclinical phase of dementia.
- 23 September 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9) , e12853
Open AccessSelective Disruption of the Cerebral Neocortex in Alzheimer's Disease
Alzheimer's disease (AD) and its transitional state mild cognitive impairment (MCI) are characterized by amyloid plaque and tau neurofibrillary tangle (NFT) deposition within the cerebral neocortex and neuronal loss within the hippocampal formation. However, the precise relationship between pathologic changes in neocortical regions and hippocampal atrophy is largely unknown. In this study, combining structural MRI scans and automated image analysis tools with reduced cerebrospinal fluid (CSF) Aß levels, a surrogate for intra-cranial amyloid plaques and elevated CSF phosphorylated tau (p-tau) levels, a surrogate for neocortical NFTs, we examined the relationship between the presence of Alzheimer's pathology, gray matter thickness of select neocortical regions, and hippocampal volume in cognitively normal older participants and individuals with MCI and AD (n = 724). Amongst all 3 groups, only select heteromodal cortical regions significantly correlated with hippocampal volume. Amongst MCI and AD individuals, gray matter thickness of the entorhinal cortex and inferior temporal gyrus significantly predicted longitudinal hippocampal volume loss in both amyloid positive and p-tau positive individuals. Amongst cognitively normal older adults, thinning only within the medial portion of the orbital frontal cortex significantly differentiated amyloid positive from amyloid negative individuals whereas thinning only within the entorhinal cortex significantly discriminated p-tau positive from p-tau negative individuals. Cortical Aβ and tau pathology affects gray matter thinning within select neocortical regions and potentially contributes to downstream hippocampal degeneration. Neocortical Alzheimer's pathology is evident even amongst older asymptomatic individuals suggesting the existence of a preclinical phase of dementia.
- 1 August 2010
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (8) , 1364-1374
Automated MRI measures predict progression to Alzheimer's disease
- 1 August 2010
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (8) , 1364-1374
Automated MRI measures predict progression to Alzheimer's disease
- 1 October 2008
- Published by Elsevier in Medical Image Analysis
- Vol. 12 (5) , 603-615
Effects of registration regularization and atlas sharpness on segmentation accuracy
- 1 October 2008
- Published by Elsevier in Medical Image Analysis
- Vol. 12 (5) , 603-615
Effects of registration regularization and atlas sharpness on segmentation accuracy